Search anything
Ctrl+K
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Aditya Ispat Ltd. reports a significant 29.8% year-over-year drop in December 2025 sales, prompting the board to explore asset sales to manage operational losses and high finance costs.
Aditya Ispat Ltd. is exploring strategic options, including asset sales and capital infusion, to address significant operational losses and an eroded net worth reported in its latest financials.
Aditya Ispat Ltd. reports a significant 29.8% year-on-year decline in December 2025 sales, prompting the board to explore asset sales to address mounting operational losses.
Aditya Ispat reports a significant 29.8% year-on-year decline in December 2025 sales, prompting the board to consider asset sales and capital infusion to address mounting losses.
US President Donald Trump signed an executive order for a new 10% global tariff after the Supreme Court invalidated his previous use of emergency powers for trade duties.
Swiss parent Novartis AG announces the sale of its entire 70.68% stake in Novartis India for ₹1,446 crore, triggering a mandatory open offer and a 20% stock surge.
The Indian stock market faces a cautious session as traders weigh strong domestic industrial data against mixed global signals ahead of the Economic Survey 2026.
Gujarat-based Omnitech Engineering is set to launch its Rs 583 crore IPO from February 25 to 27, with a price band of Rs 216-227 per share.
Novartis India's shares surged nearly 20% after its Swiss parent, Novartis AG, announced the sale of its entire 70.68% stake to a ChrysCapital-led consortium for ₹1,446 crore.
Swiss drugmaker Novartis AG is selling its entire 70.68% stake in its listed Indian subsidiary to a ChrysCapital-led consortium for $159 million, marking its exit from India's public markets.
India's market regulator, SEBI, has issued a show-cause notice to Zee Entertainment and its leadership over allegations of significant fund diversion, reviving a multi-year investigation.
Swiss pharmaceutical giant Novartis AG announced the sale of its entire 70.68% stake in its listed Indian arm to a consortium led by ChrysCapital for ₹1,446 crore.
Swiss pharmaceutical giant Novartis AG has agreed to sell its entire 70.68% stake in its Indian-listed entity to a consortium led by private equity firm ChrysCapital.
Morgan Stanley reiterates an 'overweight' rating on Reliance Industries, forecasting an 18% stock upside following the company's massive ₹10 lakh crore AI investment announcement.
Novartis AG agrees to sell its 70.68% stake in Novartis India to a ChrysCapital-led consortium, triggering a mandatory open offer and causing shares to surge.
Tata Group, TCS, and OpenAI have announced a strategic partnership to build AI infrastructure, develop enterprise solutions, and upskill youth in India.
